Anuh Pharma Limited has informed the Exchange about Disclosure under Regulation 30
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anuh Pharma Limited has submitted a disclosure to the stock exchange under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations. The specific details of the material event or information being disclosed are not available in the headline. Regulation 30 filings typically cover corporate actions such as changes in management, orders from regulatory bodies, mergers, acquisitions, or other material developments.
Without access to the full filing, the precise impact on shareholders and the stock cannot be determined. Investors should review the detailed disclosure on the NSE/BSE portal to understand the nature and significance of the announcement.